Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANNX Annexon, Inc.

盘后交易 08-20 19:00:25 EDT

5.18

-0.32

-5.82%

盘后5.27

+0.09+1.74%

18:45 EDT

最高5.47	最低5.11	成交量167.01万
今开5.41	昨收5.50	日振幅6.55%
总市值9.84亿	流通市值8.50亿	总股本1.90亿
成交额870.58万	换手率1.02%	流通股本1.64亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANNX","market":"US","secType":"STK","nameCN":"Annexon, Inc.","latestPrice":5.18,"timestamp":1787256000000,"preClose":5.5,"halted":0,"volume":1670075,"hourTrading":{"tag":"盘后","latestPrice":5.27,"preClose":5.18,"latestTime":"18:45 EDT","volume":29495,"amount":152822.119055,"timestamp":1787265917459,"change":0.09,"changeRate":0.017375,"amplitude":0.032819},"delay":0,"changeRate":-0.05818181818181823,"floatShares":164000000,"shares":190000000,"eps":-1.127133,"marketStatus":"盘后交易","change":-0.32,"latestTime":"08-20 19:00:25 EDT","open":5.41,"high":5.465,"low":5.105,"amount":8705839.441255,"amplitude":0.065455,"askPrice":6.51,"askSize":100,"bidPrice":5.08,"bidSize":3900,"shortable":3,"etf":0,"ttmEps":-1.127133,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787270400000},"marketStatusCode":4,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":5.5,"preHourTrading":{"tag":"盘前","latestPrice":5.45,"preClose":5.5,"latestTime":"09:13 EDT","volume":6123,"amount":33411.2595999,"timestamp":1787231583475,"change":-0.05,"changeRate":-0.009091,"amplitude":0.132727},"postHourTrading":{"tag":"盘后","latestPrice":5.27,"preClose":5.18,"latestTime":"18:45 EDT","volume":29495,"amount":152822.119055,"timestamp":1787265917459,"change":0.09,"changeRate":0.017375,"amplitude":0.032819},"volumeRatio":0.539181,"impliedVol":0.6663,"impliedVolPercentile":0.2829},"requestUrl":"/m/hq/s/ANNX","defaultTab":"news","newsList":[{"id":"1114586122","title":"Annexon, Inc. 披露2026年第二季度财务业绩、业务进展及关键预期里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1114586122","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114586122?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:06","pubTimestamp":1786529187,"startTime":"0","endTime":"0","summary":"Annexon, Inc. 正式发布了2026年第二季度的财务报告，同步更新了业务运营状况，并展望了未来阶段所期待达成的关键里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198390747","title":"Annexon扩大Vonaprument治疗地理萎缩的三期临床项目：新增第24个月双重主要终点，补充第15个月主要终点，并启动开放标签扩展研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1198390747","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198390747?lang=zh_cn&edition=full","pubTime":"2026-08-12 18:03","pubTimestamp":1786528993,"startTime":"0","endTime":"0","summary":"Annexon, Inc. 正在推进其Vonaprument药物针对地理萎缩（GA）的三期临床项目。该公司不仅新增了第24个月的双重主要终点，用以补充原有的第15个月主要终点，还正式启动了一项开放标签扩展研究。这一举措显著扩大了该项目的范围与深度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167850951","title":"Annexon任命知名视网膜外科医生兼生物科技企业家Mark S. Blumenkranz医学博士、外科学硕士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1167850951","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167850951?lang=zh_cn&edition=full","pubTime":"2026-08-11 04:06","pubTimestamp":1786392378,"startTime":"0","endTime":"0","summary":"Annexon, Inc.宣布，已正式任命Mark S. Blumenkranz医学博士、外科学硕士加入其董事会。Blumenkranz博士是一位享誉全球的视网膜外科专家，同时亦是一位卓有建树的生物技术企业家。此次任命，无疑将为公司注入深厚的专业洞察与丰富的行业经验，推动其战略布局迈向新高度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173273205","title":"Annexon公布2025年第四季度及全年财务业绩，披露产品管线进展与关键预期里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1173273205","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173273205?lang=zh_cn&edition=full","pubTime":"2026-03-31 04:02","pubTimestamp":1774900933,"startTime":"0","endTime":"0","summary":"Annexon, Inc.近日公布了其2025年第四季度及全年财务业绩，同时展示了公司在研产品组合的重要进展，并明确了未来一段时间内值得关注的关键预期里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518209991","title":"Annexon, Inc.盘中异动 股价大跌5.07%报2.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518209991?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:51","pubTimestamp":1741629114,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时51分，Annexon, Inc.股票出现波动，股价急速下跌5.07%。截至发稿，该股报2.62美元/股，成交量36.4619万股，换手率0.33%，振幅6.32%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311015154abf35ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311015154abf35ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518447795","title":"Annexon, Inc.2024财年实现净利润-1.38亿美元，同比减少2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518447795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518447795?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449676,"startTime":"0","endTime":"0","summary":"3月9日，Annexon, Inc.公布财报，公告显示公司2024财年净利润为-1.38亿美元，同比减少2.99%；其中营业收入为0.00美元，每股基本收益为-1.01美元。从资产负债表来看，Annexon, Inc.总负债56.97百万美元，其中短期债务2.52百万美元，资产负债比为0.07，流动比率为0.11。机构评级：截至2025年3月9日，当前有5家机构对Annexon, Inc.目标价做出预测，其中目标均价为14.40美元，其中最低目标价为10.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000246abef9896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000246abef9896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517877162","title":"Annexon, Inc.盘中异动 早盘大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517877162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517877162?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:26","pubTimestamp":1741274804,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时26分，Annexon, Inc.股票出现波动，股价快速跳水5.07%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306232644989ebfd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306232644989ebfd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517944704","title":"Annexon, Inc.盘中异动 股价大涨5.06%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517944704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517944704?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:02","pubTimestamp":1741194120,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时02分，Annexon, Inc.股票出现波动，股价大幅拉升5.06%。截至发稿，该股报2.60美元/股，成交量30.7254万股，换手率0.28%，振幅5.67%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.17%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306010201a260f157&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306010201a260f157&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517601696","title":"Annexon, Inc.盘中异动 临近午盘快速拉升6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517601696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517601696?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:48","pubTimestamp":1741106901,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时48分，Annexon, Inc.股票出现异动，股价快速上涨6.28%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305004822a25f2a52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305004822a25f2a52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516658291","title":"Annexon, Inc.盘中异动 早盘股价大跌5.11%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516658291?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:55","pubTimestamp":1741017354,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时55分，Annexon, Inc.股票出现波动，股价快速下跌5.11%。截至发稿，该股报2.51美元/股，成交量21.8671万股，换手率0.21%，振幅9.09%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235555a25d5ae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235555a25d5ae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119217643","title":"Annexon第四季度每股收益$(0.33) vs 去年同期$(0.36)","url":"https://stock-news.laohu8.com/highlight/detail?id=1119217643","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119217643?lang=zh_cn&edition=full","pubTime":"2025-03-03 21:14","pubTimestamp":1741007654,"startTime":"0","endTime":"0","summary":"Annexon第四季度每股收益$(0.33) vs 去年同期$(0.36)以上内容来自Benzinga Earnings专栏，原文如下：Annexon Q4 EPS $(0.33) vs $(0.36) YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Annexon第四季度每股收益$(0.33) vs 去年同期$(0.36)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516364301","title":"Annexon, Inc.盘中异动 临近收盘股价大涨5.20%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516364301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516364301?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:52","pubTimestamp":1740775936,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时52分，Annexon, Inc.股票出现异动，股价急速上涨5.20%。截至发稿，该股报2.63美元/股，成交量80.7779万股，换手率0.76%，振幅8.20%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045216abe13de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045216abe13de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514703421","title":"Annexon, Inc.盘中异动 临近收盘急速跳水5.16%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514703421?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:39","pubTimestamp":1740429591,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时39分，Annexon, Inc.股票出现异动，股价快速下跌5.16%。截至发稿，该股报2.67美元/股，成交量56.2921万股，换手率0.53%，振幅5.87%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504395198913d08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504395198913d08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512573485","title":"Annexon, Inc.盘中异动 股价大涨5.00%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512573485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512573485?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:45","pubTimestamp":1739976318,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时45分，Annexon, Inc.股票出现异动，股价快速拉升5.00%。截至发稿，该股报2.84美元/股，成交量10.2622万股，换手率0.10%，振幅6.67%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224518abd50165&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224518abd50165&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512198821","title":"Annexon, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512198821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512198821?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:38","pubTimestamp":1739900293,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时38分，Annexon, Inc.股票出现异动，股价快速下挫5.21%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为547.33%、190.20%、158.68%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219013814abd3d656&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219013814abd3d656&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511691730","title":"Annexon, Inc.盘中异动 股价大涨5.32%报3.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511691730?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:45","pubTimestamp":1739544344,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时45分，Annexon, Inc.股票出现异动，股价快速拉升5.32%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1707.70%、458.52%、412.57%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224545a246045b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224545a246045b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510877883","title":"Annexon, Inc.盘中异动 股价大跌5.00%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510877883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510877883?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:43","pubTimestamp":1739285008,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时43分，Annexon, Inc.股票出现异动，股价急速下跌5.00%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2318.03%、607.17%、245.95%，振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.，振幅分别为33.04%、33.02%、31.17%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224328abcb08e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224328abcb08e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509469476","title":"Annexon, Inc.盘中异动 急速拉升5.26%报3.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509469476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509469476?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:32","pubTimestamp":1738686757,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时32分，Annexon, Inc.股票出现波动，股价快速上涨5.26%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.50%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1658.92%、931.17%、534.36%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205003237abc23f64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205003237abc23f64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508216141","title":"Annexon, Inc.盘中异动 早盘急速下跌5.21%报3.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508216141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508216141?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:00","pubTimestamp":1738594849,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时00分，Annexon, Inc.股票出现波动，股价大幅下跌5.21%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Gh Research Plc、Invivyd, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Cyclerion Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为245.73%、81.27%、36.01%，振幅较大的相关个股有Invivyd, Inc.、Seastar Medical Holding Corporation、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为64.33%、33.48%、33.33%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323005096170104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323005096170104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508991571","title":"Annexon, Inc.盘中异动 急速下跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508991571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508991571?lang=zh_cn&edition=full","pubTime":"2025-02-01 03:06","pubTimestamp":1738350406,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日03时06分，Annexon, Inc.股票出现异动，股价急速下挫5.18%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Metsera, Inc.、Cyclerion Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2741.44%、2032.38%、200.97%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corporation，振幅分别为121.11%、80.00%、69.36%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103064796150af1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103064796150af1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annexonbio.com;ir.annexonbio.com","stockEarnings":[{"period":"1week","weight":0.0319},{"period":"1month","weight":-0.0126},{"period":"3month","weight":0.011},{"period":"6month","weight":0.1224},{"period":"1year","weight":1.5114},{"period":"ytd","weight":0.0956}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annexon, Inc.于2011年3月3日根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于开发针对经典补体介导的身体，大脑和眼睛疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.030084},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.059583},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.125232},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.052375},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.010608},{"month":6,"riseRate":1,"avgChangeRate":0.114697},{"month":7,"riseRate":0.333333,"avgChangeRate":0.074178},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.010367},{"month":9,"riseRate":0.833333,"avgChangeRate":0.131997},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.07122},{"month":11,"riseRate":0.666667,"avgChangeRate":0.092843},{"month":12,"riseRate":0.5,"avgChangeRate":0.09677}],"exchange":"NASDAQ","name":"Annexon, Inc.","nameEN":"Annexon, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annexon, Inc.,ANNX,Annexon, Inc.股票,Annexon, Inc.股票老虎,Annexon, Inc.股票老虎国际,Annexon, Inc.行情,Annexon, Inc.股票行情,Annexon, Inc.股价,Annexon, Inc.股市,Annexon, Inc.股票价格,Annexon, Inc.股票交易,Annexon, Inc.股票购买,Annexon, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}